title: Pazopanib can preserve cosmetic quality of life even in end-stage angiosarcoma.
authors: Department of Dermatology, Hokkaido University Graduate School of Medicine, Kita-ku, Sapporo, Japan.
authors: S
authors: S
authors: Kitamura
authors: Department of Dermatology, Hokkaido University Graduate School of Medicine, Kita-ku, Sapporo, Japan. hata07jp@yahoo.co.jp.
authors: H
authors: H
authors: Hata
authors: Department of Dermatology, Hokkaido University Graduate School of Medicine, Kita-ku, Sapporo, Japan.
authors: K
authors: K
authors: Imafuku
authors: Department of Dermatology, Hokkaido University Graduate School of Medicine, Kita-ku, Sapporo, Japan.
authors: N
authors: N
authors: Haga
authors: Department of Dermatology, Hokkaido University Graduate School of Medicine, Kita-ku, Sapporo, Japan.
authors: E
authors: E
authors: Homma
authors: Department of Dermatology, Hokkaido University Graduate School of Medicine, Kita-ku, Sapporo, Japan.
authors: H
authors: H
authors: Shimizu
mesh_terms: D000369:Aged, 80 and over; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D006258:Head and Neck Neoplasms / Q000188:drug therapy*; D006394:Hemangiosarcoma / Q000188:drug therapy*; D006801:Humans; D007191:Indazoles; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D011788:Quality of Life; D012535:Scalp; D012878:Skin Neoplasms / Q000188:drug therapy*; D013449:Sulfonamides / Q000627:therapeutic use*
chemical_list: D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents; D007191:Indazoles; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D013449:Sulfonamides; C516667:pazopanib